Median KS test (Q1-Q3), pb | ||||||
---|---|---|---|---|---|---|
Median IT with 1st and 3rd quartiles and Kolmogorov-Smirnov (KS) test | ESBL-positive E. coli | ESBL-positive E. cloacae | ESBL-positive K. pneumoniae | |||
Number of isolates (total = 1078) | ||||||
Hospital A | 1.5 (0–9), n = 186 | 8.5 (2–23), n = 76 | 8 (1–23), n = 185 | |||
0.13 | 0.009 | 0.04 | ||||
Hospital B | 3 (0–13), n = 264 | 17 (7–31), n = 116 | 13 (3–28), n = 161 | |||
Unit’s activity (n = 1077) | ||||||
Medicine (reference) | 2 (0–8), n = 229 | 10.5 (2–31), n = 74 | 8 (1–23), n = 161 | |||
Surgery | 2.5 (0–14), n = 152 | 0.30 | 13 (5–24), n = 54 | 0.66 | 7 (1–17), n = 85 | 0.67 |
ICU | 5 (1.5–13.5), n = 68 | 0.04 | 15 (7.5–28.5), n = 64 | 0.07 | 17.5 (7.5–37), n = 100 | 0.003 |
Age (n = 1058) | ||||||
Children (<14 y-old) | 2.5 (0–9.5), n = 120 | 7 (1–22), n = 37 | 8 (2–26.5), n = 136 | |||
0.97 | 0.08 | 0.61 | ||||
Adult | 2 (0–11), n = 318 | 14 (6–27), n = 153 | 11 (1–24), n = 148 | |||
Gender (n = 1078) | ||||||
Men | 4 (0–15), n = 199 | 14 (5–28.5), n = 112 | 10 (1–24), n = 198 | |||
0.09 | 0.87 | 0.61 | ||||
Women | 2 (0–8), n = 251 | 14 (5–27), n = 80 | 9 (1–25.5), n = 148 | |||
Clinical site (n = 961) | ||||||
Urine (reference) | 2 (0–10.5), n = 316 | 14 (4–28.5), n = 96 | 8 (1–23), n = 181 | |||
Blood culture | 2 (0–7), n = 37 | 0.67 | 15.5 (5–28), n = 26 | 0.99 | 11 (1–28), n = 33 | 0.41 |
Respiratory protected | 5 (1–14), n = 11 | 0.94 | 12 (5.5–24), n = 12 | 0.63 | 19 (5–62), n = 19 | 0.10 |
Respiratory unprotected | 2 (1–7), n = 12 | 0.96 | 13 (2–26), n = 14 | 0.86 | 8.5 (3–21), n = 38 | 0.06 |
Intravascular devices | 8 (4–9), n = 7 | 0.05 | 14 (7–25), n = 21 | 0.18 | 14 (9–21), n = 27 | 0.006 |
Deep purulent samples | 17 (1–41), n = 17 | 0.007 | 18 (4–27), n = 7 | 0.99 | 19 (14–21), n = 6 | 0.19 |
Total by ESBL producer | 2 (0–11), n = 450 | 14 (5–28), n = 192 | 10 (1–24), n = 346 |